-
Je něco špatně v tomto záznamu ?
The role of cannabinoids in the treatment of cancer
L. Vecera, T. Gabrhelik, P. Prasil, P. Stourac
Jazyk angličtina Země Slovensko
- MeSH
- antitumorózní látky farmakologie terapeutické užití MeSH
- apoptóza účinky léků MeSH
- autofagie účinky léků MeSH
- ceramidy metabolismus MeSH
- inhibitory angiogeneze farmakologie MeSH
- kanabinoidy * terapeutické užití MeSH
- lidé MeSH
- metastázy nádorů farmakoterapie MeSH
- nádory * farmakoterapie MeSH
- receptory kanabinoidní metabolismus MeSH
- Check Tag
- lidé MeSH
AIM: The aim of this review article is to summarize current knowledge about the role of cannabinoids and cannabinoid receptors in tumor disease modulation and to evaluate comprehensively the use of cannabinoids in cancer patients. METHOD: According to the PRISMA protocol, we have included data from a total of 105 articles. RESULTS: Cannabinoids affect cancer progression by three mechanisms. The most important mechanism is the stimulation of autophagy and affecting the signaling pathways leading to apoptosis. The most important mechanism of this process is the accumulation of ceramide. Cannabinoids also stimulate apoptosis by mechanisms independent of autophagy. Other mechanisms by which cannabinoids affect tumor growth are inhibition of tumor angiogenesis, invasiveness, metastasis, and the modulation of the anti-tumor immune response. CONCLUSION: In addition to the symptomatic therapy of cancer patients, the antitumor effects of cannabinoids (whether in monotherapy or in combination with other cancer therapies) have promising potential in the treatment of cancer patients. More clinical trials are needed to demonstrate the antitumor effect of cannabinoids (Tab. 1, Fig. 1, Ref. 167).
Department of Anaesthesia and Intensive Care Medicine District Hospital Amstetten Amstetten Austria
Department of Emergency Medicine The Tomas Bata Hospital in Zlin Zlin Czech Republic
Citace poskytuje Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21024802
- 003
- CZ-PrNML
- 005
- 20250121222846.0
- 007
- cr|cn|
- 008
- 211012s2020 xo fs 000 0|eng||
- 009
- AR
- 024 0_
- $a 10.4149/BLL_2020_012 $2 doi
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Večeřa, Lubomír $7 xx0224302 $u Department of Emergency Medicine, The Tomas Bata Hospital in Zlin, Zlin, Czech Republic $u Department of Paediatric Anaesthesiology and Intensive Care Medicine, Medical Faculty of Masaryk University, University Hospital Brno, Brno, Czech Republic
- 245 14
- $a The role of cannabinoids in the treatment of cancer / $c L. Vecera, T. Gabrhelik, P. Prasil, P. Stourac
- 504 __
- $a Literatura
- 520 3_
- $a AIM: The aim of this review article is to summarize current knowledge about the role of cannabinoids and cannabinoid receptors in tumor disease modulation and to evaluate comprehensively the use of cannabinoids in cancer patients. METHOD: According to the PRISMA protocol, we have included data from a total of 105 articles. RESULTS: Cannabinoids affect cancer progression by three mechanisms. The most important mechanism is the stimulation of autophagy and affecting the signaling pathways leading to apoptosis. The most important mechanism of this process is the accumulation of ceramide. Cannabinoids also stimulate apoptosis by mechanisms independent of autophagy. Other mechanisms by which cannabinoids affect tumor growth are inhibition of tumor angiogenesis, invasiveness, metastasis, and the modulation of the anti-tumor immune response. CONCLUSION: In addition to the symptomatic therapy of cancer patients, the antitumor effects of cannabinoids (whether in monotherapy or in combination with other cancer therapies) have promising potential in the treatment of cancer patients. More clinical trials are needed to demonstrate the antitumor effect of cannabinoids (Tab. 1, Fig. 1, Ref. 167).
- 650 07
- $a lidé $7 D006801 $2 czmesh
- 650 17
- $a kanabinoidy $x terapeutické užití $7 D002186 $2 czmesh
- 650 17
- $a nádory $x farmakoterapie $7 D009369 $2 czmesh
- 650 07
- $a receptory kanabinoidní $x metabolismus $7 D043882 $2 czmesh
- 650 07
- $a apoptóza $x účinky léků $7 D017209 $2 czmesh
- 650 07
- $a autofagie $x účinky léků $7 D001343 $2 czmesh
- 650 07
- $a inhibitory angiogeneze $x farmakologie $7 D020533 $2 czmesh
- 650 07
- $a metastázy nádorů $x farmakoterapie $7 D009362 $2 czmesh
- 650 07
- $a ceramidy $x metabolismus $7 D002518 $2 czmesh
- 650 07
- $a antitumorózní látky $x farmakologie $x terapeutické užití $7 D000970 $2 czmesh
- 700 1_
- $a Gabrhelík, Tomáš $7 xx0105792 $u Department of Anaesthesiology, Resuscitation and Intensive Care Medicine, The Tomas Bata Hospital in Zlin, Zlin, Czech Republic
- 700 1_
- $a Prášil, Petr $7 xx0224301 $u Department of Anaesthesia and Intensive Care Medicine, District Hospital Amstetten, Amstetten, Austria
- 700 1_
- $a Štourač, Pavel, $d 1959- $7 xx0060352 $u Department of Paediatric Anaesthesiology and Intensive Care Medicine, Medical Faculty of Masaryk University, University Hospital Brno, Brno, Czech Republic
- 773 0_
- $t Bratislavské lekárske listy $x 0006-9248 $g Roč. 121, č. 1 (2020), s. 79-95 $w MED00000845
- 856 41
- $u http://www.elis.sk/download_file.php?product_id=6509&session_id=vqcv5omiqd8n4relp2g02i6ia2 $y plný text volně přístupný
- 910 __
- $a ABA008 $b online $c 1067 $y 0 $z 0
- 990 __
- $a 20211012144111 $b ABA008
- 991 __
- $a 20250121222856 $b ABA008
- 999 __
- $a kom $b bmc $g 1707779 $s 1145309
- BAS __
- $a 3 $a 4
- BMC __
- $a 2020 $b 121 $c 1 $d 79-95 $i 0006-9248 $m Bratislavské lekárske listy $x MED00000845
- LZP __
- $c NLK192 $d 20250121 $a NLK 2021-43/kv
